Smoking Cessation in Substance Abuse Treatment Patients: A Feasibility Study
2 other identifiers
interventional
80
1 country
1
Brief Summary
The purpose of this study is to compare the effects of self-help materials for smoking cessation and self-help materials for smoking cessation plus prize-based contingency management (CM), in which prize incentives are available for breath and saliva samples that indicate smoking abstinence, in substance abuse treatment patients who want to quit smoking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jan 2004
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 4, 2006
CompletedFirst Posted
Study publicly available on registry
December 6, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedNovember 21, 2011
November 1, 2011
3.2 years
December 4, 2006
November 17, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Percent negative CO readings
Percent negative cotinine readings
Longest period of continuous abstinence
Secondary Outcomes (4)
Self-reported frequency and severity of smoking
Objective substance use
Self-reported substance use
Treatment retention
Interventions
Eligibility Criteria
You may qualify if:
- meets diagnostic criteria for alcohol, cocaine or heroin abuse or dependence
- self-report daily smoking for at least the past year
- CO \> 8ppm
- interested in quitting smoking while in treatment,
- minimum age 18 years old
- willing to provide names, addresses and phone numbers of individuals to assist in locating the patient for follow-up evaluations
- English speaking
You may not qualify if:
- current use of NRT
- current use of bupropion
- serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, suicide risk)
- dementia (Mini-mental status score of \<23)
- currently participating in another CM study at the clinic
- in recovery for pathological gambling
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Connecticut Health Center
Farmington, Connecticut, 06030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sheila M Alessi, PhD
UConn Health
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2006
First Posted
December 6, 2006
Study Start
January 1, 2004
Primary Completion
March 1, 2007
Study Completion
March 1, 2007
Last Updated
November 21, 2011
Record last verified: 2011-11